Back to News
Market Impact: 0.42

Earnings call transcript: Howmet Aerospace tops Q2 2026 estimates and lifts outlook

+2
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsCapital Returns (Dividends / Buybacks)M&A & RestructuringCredit & Bond MarketsEnergy Markets & Prices
Earnings call transcript: Howmet Aerospace tops Q2 2026 estimates and lifts outlook

Howmet Aerospace reported Q2 2026 adjusted EPS of $1.33 on $2.55B revenue, beating consensus ($1.24 EPS; $2.43B sales) and expanding EBITDA 39% YoY with EBITDA margin up 340 bps to 32.1%. The company raised full-year 2026 guidance to $10.05B revenue, $3.23B EBITDA, $5.27 EPS and $1.9B free cash flow, and guided Q3 revenue to $2.75B with EPS of $1.35. Liquidity/financing remains solid (net debt/EBITDA 1.4x; cash $564M), while capital returns increased with a 17% dividend hike to 14 cents and buybacks continuing ($800M YTD), supported by strong operating momentum despite CAM integration and higher capex needs.

Analysis

Howmet is not just a quarterly beat; it is a confirmation that aerospace and power-generation supply chains are still capacity-bound, which preserves pricing power longer than the market usually prices in. The key second-order effect is that every incremental rate increase at Boeing/Airbus or industrial gas turbine OEMs now requires more capex, more tooling lead time, and more working capital across the ecosystem, which should keep HWM’s mix and margin profile superior versus the broader aerospace group.

The market is likely underappreciating the asymmetry between near-term expectation fatigue and medium-term operating leverage. If AI/data-center power demand remains intact, HWM’s gas-turbine exposure becomes one of the cleaner “AI infrastructure” beneficiaries outside semis, while a true slowdown would not hit immediately because blades/spares/aftermarket are multi-quarter revenue streams. The bigger risk is not demand today but a pause in OEM order conversion or a deferral of 2027 rate plans, which would show up first in sentiment before it appears in reported revenue.

Contrarian view: consensus may be too focused on the already-rich valuation and too dismissive of the fact that management is telegraphing a 2027-2030 capacity expansion cycle. That argues the stock can keep compounding even if multiple expansion stalls, but the setup is not a great chase at current levels. The clean falsifier is any November update that fails to raise the 2027 revenue/capex roadmap, or a material slowdown in commercial aero spares growth over the next 1-2 quarters.

More News